Registro:

Referencias:

• Lechner, K., Niesser, H., Thaler, E., Coagulation abnormalities in liver disease (1997) Semi Thromb Hemos, 40, pp. 40-45
• Martínez, J., Holburn, R., Shapiro, S., Erslev, A., Fibrinogen Philadelphia (1974) J Clin Investig, 53, pp. 600-611
• Gralnick, H., Henderson, E., Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment (1971) Cancer, 27, pp. 1313-1316
• Heinrich, J., Schulte, H., Balleisen, L., Assmann, G., Van de Loo, J., Predictive value of haemostatic variables in the PROCAM study (1991) Thromb Haemostas, 65, p. 815
• Krobot, K., Hense, H.W., Cremer, P., Eberle, E., Keil, U., Determinants of plasma fibrinogen: Relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990 (1992) Arterioscler Thromb, 12, pp. 780-788
• Balleisen, L., Bailey, J., Epping, P., Schulte, H.H., Van de Loo, J.J., Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause (1985) Thromb Haemostas, 54, pp. 475-479
• Berglund, U., Wallentin, L., Von Schenck, H., Platelet function and plama fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of miocardial infarction (1988) Thromb Haemostas, 60, pp. 21-24
• Meade, T., Imeson, Stirling, Y., Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease (1987) Lancet, 2, pp. 986-988
• Pechetl, A., Alexander, B., Increased clotting factors in pregnancy (1961) N Engl J Med, 265, pp. 1093-1095
• Haverkate, F., Thomson, S., Duckest, F., Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group (1995) Thromb Haemostas, 73, pp. 561-567
• Downtown, S., Coten, H., Acute phase reactants in inflamation and infection (1988) Sem Hematol, 25, pp. 84-90
• Meade, T.W., Mellows, S.S., Brozovic, M.M., Miller, G.J., Chakrabarti, R.R., North, W.R., Haemostatic funtion and ischaemic heart disease: Principal results of the Northwick Park Heart Study (1986) Lancet, 2, pp. 533-537
• Kannel, W., Wolf, P., Castelli, W., D'Agostino, R., Fibrinogen and risk of cardiovascular disease. The Framingham Study (1987) JAMA, 258, pp. 1183-1186
• Wilhelmsen, L., Svarsudd, K., Korsanbengtsen, K., Larson, B., Wellin, L., Tibblin, G., Fibrinogen as a risk factor for stroke and myocardial infarction (1984) N Engl J Med, 311, pp. 501-505
• Qizilbash, N., Fibrinogen and cerebrovascular disease: An overview (1994) Blood Coagul Fibrinolysis, (SUPPL. 2), p. 14. , Oct
• Ridker, P., Hennkens, C., Hemostatic risk factor for coronary heart disease (1991) Circulation, 83, pp. 1098-1100
• Von Clauss, A., Gerinnunphisyologische schnellmrthode zur bestimmung des fibrinogens (1957) Acta Haematol, 17, pp. 237-246
• Rossi, E., Mondonico, P., Lombardi, A., Preda, L., Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers (1988) Thromb Res, 52, pp. 453-468
• De Cristofaro, R., Landolfi, R., Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: Applicability and limitations (1998) Blood Coagul Fibrinolysis, 9, pp. 251-259
• Hoffmann, J.J.M., Verhappen, M.A.L., Automated nephelometry of fibrinogen: Analytical Performance and observations during thrombolytic therapy (1988) Clin Chem, 34 (10), pp. 2135-2140
• Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between two methods of clinical measurement (1986) Lancet, 1, pp. 307-310

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------